Effect of captopril on plasma prostacyclin concentration in essential hypertensive patients
- 30 November 1985
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 20 (2), 187-195
- https://doi.org/10.1016/0262-1746(85)90009-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (58480239)
This publication has 22 references indexed in Scilit:
- Suppressive Effect of Captopril on Platelet Aggregation in Essential HypertensionJournal of Cardiovascular Pharmacology, 1984
- Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1α in essential hypertensionThe American Journal of Cardiology, 1983
- Effects of captopril on prostaglandin and natriuresis in patients with essential hypertensionThe American Journal of Cardiology, 1982
- Angiotensin Converting Enzyme (ACE) InhibitorsAnnual Review of Pharmacology and Toxicology, 1982
- Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.Hypertension, 1981
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- Is prostacyclin a physiologically important circulating anti-platelet agent?Nature, 1980
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human PlasmaJournal of Clinical Investigation, 1973